Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States-Reference-Cited by-同舟云学术

Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States

Published:2018-12 Issue:12 Volume:13 Page:1842-1850
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Ramalingam Sendhilnathan,Dinan Michaela A.,Crawford Jeffrey

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Fast stats. 2017; https://seer.cancer.gov/faststats/. Accessed October 3, 2017.

2. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system;Chen;Cancer,2014

3. National Cancer Institute. Drugs approved for lung cancer. https://www.cancer.gov/about-cancer/treatment/drugs/lung. Accessed September 9, 2017.

4. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004

5. The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies;Scagliotti;Oncologist,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors;Frontiers in Oncology;2024-04-18

2. Treatment at Twilight: An Analysis of Therapy Patterns and Outcomes in Adults 80 Years and Older With Advanced or Metastatic NSCLC;JTO Clinical and Research Reports;2023-10

3. Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States;The Oncologist;2023-06-26

4. Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer;Clinical Lung Cancer;2023-06

5. Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database;Scientific Reports;2023-05-20